Chemical Compound

CEFAPAROLE

CAS Registry Number 51627-20-4
CEFAPAROLE chemical structure
Primary Record

CEFAPAROLE

Note: Only for scientific research or as raw materials for production.

In stock
7,861 g
Purity
99.3 %
CAS
51627-20-4

Compound Identifiers & Properties

CAS
51627-20-4
PubChem CID
10413379
SMILES
CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=C(C=C4)O)N)SC2)C(=O)O
Canonical SMILES
Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@H](N)c4ccc(O)cc4)[C@H]3SC2)s1

Names & Synonyms

  • CEFAPAROLE
  • Cefaparol
  • Cefaparolum
  • Cefaparole (USAN)
  • Cefaparole [USAN:INN]
  • Cefaparol [INN-Spanish]
  • Cefaparolum [INN-Latin]
  • CEFAPAROLE [INN]
  • Lilly 110264
  • CEFAPAROLE [USAN]
  • UNII-HW64W823GC
  • RefChem:124198
  • Cefaparol (INN-Spanish)
  • Cefaparolum (INN-Latin)
  • HW64W823GC
  • 51627-20-4
  • SCHEMBL193876
  • EINECS 257-325-8
  • orb1702440
  • CHEMBL2104067
  • C19H19N5O5S3
  • SBUCDZYLTRYMFG-PBFPGSCMSA-N
  • DTXSID801023695
  • ZINC4215222
  • AKOS040746681
  • C19-H19-N5-O5-S3
  • CID10413379
  • TRIFLUOROACETALDEHYDEDIMETHYLACETAL
  • J11.175I
  • NS00011585
  • 1,3-Benzodioxole,5,5'-(1,2-ethenediyl)bis
  • D03421
  • (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Q27280132
  • (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • 7-(2-Amino-2-(p-hydroxyphenyl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-3-cephem-4-carboxylic acid
  • (6R,7R)-7-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-3-
  • (6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((AMINO(4-HYDROXYPHENYL)ACETYL)AMINO)-3-(((5-METHYL-1,3,4-THIADIAZOL-2-YL)THIO)METHYL)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)))-
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(R*)))-
  • (6R,7R)-7-[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETAMIDO]-3-{[(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANYL]METHYL}-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
  • (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
  • (6R,7R)-7-[[(R)-2-Amino-2-(p-hydroxyphenyl)acetyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-{[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(5- methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azab icyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 257-325-8
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-, [6R-[6.alpha.,7.beta.(R*)]]-